Cargando…
Effectiveness of a Nutritional Mobile Application for Management of Hyperphosphatemia in Patients on Hemodialysis: A Multicenter Open-Label Randomized Clinical Trial
This study aims to determine the effectiveness of a phosphate mobile app (PMA), MyKidneyDiet-Phosphate Tracker ©2019, on hemodialysis (HD) patients with hyperphosphatemia. A multicenter, open-label, randomized controlled trial design allowed randomization of patients with hyperphosphatemia to either...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224811/ https://www.ncbi.nlm.nih.gov/pubmed/35743746 http://dx.doi.org/10.3390/jpm12060961 |
_version_ | 1784733460343029760 |
---|---|
author | Teong, Lee-Fang Khor, Ban-Hock Ng, Hi-Ming Sahathevan, Sharmela Purba, Kristo Radion Narayanan, Sreelakshmi Sankara Gafor, Abdul Halim Abdul Goh, Bak-Leong Bee, Boon-Cheak Yahya, Rosnawati Bavanandan, Sunita Wahab, Zaimi Mazlan, Sadanah Aqashiah Chinna, Karuthan Morad, Zaki Daud, Zulfitri Azuan Mat Karupaiah, Tilakavati |
author_facet | Teong, Lee-Fang Khor, Ban-Hock Ng, Hi-Ming Sahathevan, Sharmela Purba, Kristo Radion Narayanan, Sreelakshmi Sankara Gafor, Abdul Halim Abdul Goh, Bak-Leong Bee, Boon-Cheak Yahya, Rosnawati Bavanandan, Sunita Wahab, Zaimi Mazlan, Sadanah Aqashiah Chinna, Karuthan Morad, Zaki Daud, Zulfitri Azuan Mat Karupaiah, Tilakavati |
author_sort | Teong, Lee-Fang |
collection | PubMed |
description | This study aims to determine the effectiveness of a phosphate mobile app (PMA), MyKidneyDiet-Phosphate Tracker ©2019, on hemodialysis (HD) patients with hyperphosphatemia. A multicenter, open-label, randomized controlled trial design allowed randomization of patients with hyperphosphatemia to either the usual care group (UG; receiving a single dietitian-led session with an education booklet) or the PMA group (PG). Thirty-three patients in each intervention group completed the 12-week study. Post-intervention, serum phosphorus levels were reduced in both groups (PG: −0.25 ± 0.42 mmol/L, p = 0.001; UG: −0.23 ± 0.33 mmol/L, p < 0.001) without any treatment difference (p > 0.05). Patients in both groups increased their phosphate knowledge (PG: 2.18 ± 3.40, p = 0.001; UG: 2.50 ± 4.50, p = 0.003), without any treatment difference (p > 0.05). Dietary phosphorus intake of both groups was reduced (PG: −188.1 ± 161.3 mg/d, p < 0.001; UG: −266.0 ± 193.3 mg/d, p < 0.001), without any treatment difference (p > 0.05). The serum calcium levels of patients in the UG group increased significantly (0.09 ± 0.20 mmol/L, p = 0.013) but not for the PG group (−0.03 ± 0.13 mmol/L, p = 0.386), and the treatment difference was significant (p = 0.007). As per phosphate binder adherence, both groups reported a significant increase in Morisky Medication Adherence Scale scores (PG: 1.1 ± 1.2, p < 0.001; UGa: 0.8 ± 1.5, p = 0.007), without any treatment difference (p > 0.05). HD patients with hyperphosphatemia using the PMA achieved reductions in serum phosphorus levels and dietary phosphorus intakes along with improved phosphate knowledge and phosphate binder adherence that were not significantly different from a one-off dietitian intervention. However, binder dose adjustment with meal phosphate content facilitated by the PMA allowed stability of corrected calcium levels, which was not attained by UC patients whose binder dose was fixed. |
format | Online Article Text |
id | pubmed-9224811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92248112022-06-24 Effectiveness of a Nutritional Mobile Application for Management of Hyperphosphatemia in Patients on Hemodialysis: A Multicenter Open-Label Randomized Clinical Trial Teong, Lee-Fang Khor, Ban-Hock Ng, Hi-Ming Sahathevan, Sharmela Purba, Kristo Radion Narayanan, Sreelakshmi Sankara Gafor, Abdul Halim Abdul Goh, Bak-Leong Bee, Boon-Cheak Yahya, Rosnawati Bavanandan, Sunita Wahab, Zaimi Mazlan, Sadanah Aqashiah Chinna, Karuthan Morad, Zaki Daud, Zulfitri Azuan Mat Karupaiah, Tilakavati J Pers Med Article This study aims to determine the effectiveness of a phosphate mobile app (PMA), MyKidneyDiet-Phosphate Tracker ©2019, on hemodialysis (HD) patients with hyperphosphatemia. A multicenter, open-label, randomized controlled trial design allowed randomization of patients with hyperphosphatemia to either the usual care group (UG; receiving a single dietitian-led session with an education booklet) or the PMA group (PG). Thirty-three patients in each intervention group completed the 12-week study. Post-intervention, serum phosphorus levels were reduced in both groups (PG: −0.25 ± 0.42 mmol/L, p = 0.001; UG: −0.23 ± 0.33 mmol/L, p < 0.001) without any treatment difference (p > 0.05). Patients in both groups increased their phosphate knowledge (PG: 2.18 ± 3.40, p = 0.001; UG: 2.50 ± 4.50, p = 0.003), without any treatment difference (p > 0.05). Dietary phosphorus intake of both groups was reduced (PG: −188.1 ± 161.3 mg/d, p < 0.001; UG: −266.0 ± 193.3 mg/d, p < 0.001), without any treatment difference (p > 0.05). The serum calcium levels of patients in the UG group increased significantly (0.09 ± 0.20 mmol/L, p = 0.013) but not for the PG group (−0.03 ± 0.13 mmol/L, p = 0.386), and the treatment difference was significant (p = 0.007). As per phosphate binder adherence, both groups reported a significant increase in Morisky Medication Adherence Scale scores (PG: 1.1 ± 1.2, p < 0.001; UGa: 0.8 ± 1.5, p = 0.007), without any treatment difference (p > 0.05). HD patients with hyperphosphatemia using the PMA achieved reductions in serum phosphorus levels and dietary phosphorus intakes along with improved phosphate knowledge and phosphate binder adherence that were not significantly different from a one-off dietitian intervention. However, binder dose adjustment with meal phosphate content facilitated by the PMA allowed stability of corrected calcium levels, which was not attained by UC patients whose binder dose was fixed. MDPI 2022-06-12 /pmc/articles/PMC9224811/ /pubmed/35743746 http://dx.doi.org/10.3390/jpm12060961 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Teong, Lee-Fang Khor, Ban-Hock Ng, Hi-Ming Sahathevan, Sharmela Purba, Kristo Radion Narayanan, Sreelakshmi Sankara Gafor, Abdul Halim Abdul Goh, Bak-Leong Bee, Boon-Cheak Yahya, Rosnawati Bavanandan, Sunita Wahab, Zaimi Mazlan, Sadanah Aqashiah Chinna, Karuthan Morad, Zaki Daud, Zulfitri Azuan Mat Karupaiah, Tilakavati Effectiveness of a Nutritional Mobile Application for Management of Hyperphosphatemia in Patients on Hemodialysis: A Multicenter Open-Label Randomized Clinical Trial |
title | Effectiveness of a Nutritional Mobile Application for Management of Hyperphosphatemia in Patients on Hemodialysis: A Multicenter Open-Label Randomized Clinical Trial |
title_full | Effectiveness of a Nutritional Mobile Application for Management of Hyperphosphatemia in Patients on Hemodialysis: A Multicenter Open-Label Randomized Clinical Trial |
title_fullStr | Effectiveness of a Nutritional Mobile Application for Management of Hyperphosphatemia in Patients on Hemodialysis: A Multicenter Open-Label Randomized Clinical Trial |
title_full_unstemmed | Effectiveness of a Nutritional Mobile Application for Management of Hyperphosphatemia in Patients on Hemodialysis: A Multicenter Open-Label Randomized Clinical Trial |
title_short | Effectiveness of a Nutritional Mobile Application for Management of Hyperphosphatemia in Patients on Hemodialysis: A Multicenter Open-Label Randomized Clinical Trial |
title_sort | effectiveness of a nutritional mobile application for management of hyperphosphatemia in patients on hemodialysis: a multicenter open-label randomized clinical trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224811/ https://www.ncbi.nlm.nih.gov/pubmed/35743746 http://dx.doi.org/10.3390/jpm12060961 |
work_keys_str_mv | AT teongleefang effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT khorbanhock effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT nghiming effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT sahathevansharmela effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT purbakristoradion effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT narayanansreelakshmisankara effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT gaforabdulhalimabdul effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT gohbakleong effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT beebooncheak effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT yahyarosnawati effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT bavanandansunita effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT wahabzaimi effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT mazlansadanahaqashiah effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT chinnakaruthan effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT moradzaki effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT daudzulfitriazuanmat effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial AT karupaiahtilakavati effectivenessofanutritionalmobileapplicationformanagementofhyperphosphatemiainpatientsonhemodialysisamulticenteropenlabelrandomizedclinicaltrial |